目的研究固醇调节元件结合蛋白1c(sterol regulatory element binding protein 1c,SREBP1c)对肠道糖异生的调控作用。方法饥饿处理C57BL/6小鼠、SREBP1c纯合敲除型(SREBP1c-KO)和同窝野生型(SREBP1c-WT)小鼠,通过qPCR、Western blot检...目的研究固醇调节元件结合蛋白1c(sterol regulatory element binding protein 1c,SREBP1c)对肠道糖异生的调控作用。方法饥饿处理C57BL/6小鼠、SREBP1c纯合敲除型(SREBP1c-KO)和同窝野生型(SREBP1c-WT)小鼠,通过qPCR、Western blot检测糖异生途径限速酶葡萄糖-6-磷酸酶(glucose-6-phosphatase catalytic,G6PC)和磷酸烯醇式丙酮酸羧激酶(phosphoenolpyruvate carboxykinase 1,PCK1)在肝脏、空肠和回肠组织中的表达水平;在肠上皮细胞CaCo-2中过表达或敲低SREBP1c,检测细胞内G6PC和PCK1表达水平。结果饥饿处理后,C57BL/6小鼠空肠、回肠组织中G6PC、PCK1和SREBP1c表达水平均显著增加(P<0.05)。SREBP1c基因敲除后,小鼠空肠、回肠组织中由饥饿诱导的糖异生限速酶G6PC和PCK1的表达明显下调(P<0.05)。在肠上皮细胞CaCo-2中过表达SREBP1c,可显著上调糖异生途径关键酶G6PC和PCK1的表达,促进细胞内葡萄糖的产生(P<0.05);反之,敲低SREBP1c的表达,可明显下调G6PC和PCK1,抑制细胞内葡萄糖的产生(P<0.05)。结论饥饿状态下,SREBP1c可调控肠上皮细胞中糖异生限速酶G6PC和PCK1的表达,进而影响葡萄糖的生成,表明SREBP1c可能参与肠道糖异生的调控,机制有待进一步探索。展开更多
目的筛选影响胆固醇调节元件结合蛋白1a(cholesterol regulatory element binding protein,SREBP1a)蛋白稳定性的去泛素化酶,并探索其调控机制。方法通过去泛素化酶库筛选显著影响SREBP1a表达的去泛素化酶,免疫蛋白印记实验和实时荧光定...目的筛选影响胆固醇调节元件结合蛋白1a(cholesterol regulatory element binding protein,SREBP1a)蛋白稳定性的去泛素化酶,并探索其调控机制。方法通过去泛素化酶库筛选显著影响SREBP1a表达的去泛素化酶,免疫蛋白印记实验和实时荧光定量PCR(qRT-PCR)评估去泛素化酶对SREBP1a以及升脂基因表达的影响;通过红色荧光蛋白标记人源低密度脂蛋白(human Dil-low density lipoprotein,Human Dil-LDL)摄取和油红O染色等实验技术检测细胞摄取低密度脂蛋白(LDL)和脂质沉积情况。结果去泛素化酶库筛选发现泛素特异肽酶37(ubiquitin specific peptidase 37,USP37)可显著增加肝细胞SREBP1a蛋白表达水平,促进胆固醇摄取及脂质沉积。USP37基因敲除可显著降低SREBP1a蛋白表达水平,抑制升脂基因表达及脂质沉积。结论去泛素化酶USP37通过稳定SREBP1a蛋白表达,促进胆固醇摄取及脂质沉积,揭示了SREBP1a翻译后调控的新模式。展开更多
Background:Ossification of the posterior longitudinal ligament(OPLL)is a prevalent condition in orthopedics.While death-associated protein kinase 2(DAPK2)is known to play roles in cellular apoptosis and autophagy,its ...Background:Ossification of the posterior longitudinal ligament(OPLL)is a prevalent condition in orthopedics.While death-associated protein kinase 2(DAPK2)is known to play roles in cellular apoptosis and autophagy,its specific contributions to the advancement of OPLL are not well understood.Methods:Ligament fibroblasts were harvested from patients diagnosed with OPLL.Techniques such as real-time reverse transcriptasepolymerase chain reaction(RT-qPCR)and Western blot analysis were employed to assess DAPK2 levels in both ligament tissues and cultured fibroblasts.The extent of osteogenic differentiation in these cells was evaluated using an alizarin red S(ARS)staining.Additionally,the expression of ossification markers and autophagy markers was quantified.The autophagic activity was further analyzed through LC3 immunofluorescence and transmission electron microscopy(TEM).An in vivo heterotopic bone formation assay was conducted in mice to assess the role of DAPK2 in ossification.Results:Elevated DAPK2 expression was confirmed in both OPLL patient tissues and derived fibroblasts,in contrast to non-OPLL controls.Silencing of DAPK2 significantly curtailed osteogenic differentiation and autophagy in these fibroblasts,evidenced by decreased levels of LC3,and Beclin1,and reduced autophagosome formation.Additionally,DAPK2 was found to inhibit the mechanistic target of the rapamycin complex 1(mTORC1)complex’s activity.In vivo studies demonstrated that DAPK2 facilitates ossification,and this effect could be counteracted by the mTORC1 inhibitor rapamycin.Conclusion:DAPK2 enhances autophagy and osteogenic processes in OPLL through modulation of the mTORC1 pathway.展开更多
For healthspan and lifespan,ERK,AMPK and mTORC1 represent critical pathways and inflammation is a centrally important hallmark1-7.Here we examined whether IL-11,a pro-inflammatory cytokine of the IL-6 family,has a neg...For healthspan and lifespan,ERK,AMPK and mTORC1 represent critical pathways and inflammation is a centrally important hallmark1-7.Here we examined whether IL-11,a pro-inflammatory cytokine of the IL-6 family,has a negative effect on age-associated disease and lifespan.As mice age,IL-11 is upregulated across cell types and tissues to regulate an ERK-AMPK-mTORC1 axis to modulate cellular,tissue-and organismal-level ageing pathologies.Deletion of Il11 or Il11ra1 protects against metabolic decline,multi-morbidity and frailty in old age.展开更多
文摘目的研究固醇调节元件结合蛋白1c(sterol regulatory element binding protein 1c,SREBP1c)对肠道糖异生的调控作用。方法饥饿处理C57BL/6小鼠、SREBP1c纯合敲除型(SREBP1c-KO)和同窝野生型(SREBP1c-WT)小鼠,通过qPCR、Western blot检测糖异生途径限速酶葡萄糖-6-磷酸酶(glucose-6-phosphatase catalytic,G6PC)和磷酸烯醇式丙酮酸羧激酶(phosphoenolpyruvate carboxykinase 1,PCK1)在肝脏、空肠和回肠组织中的表达水平;在肠上皮细胞CaCo-2中过表达或敲低SREBP1c,检测细胞内G6PC和PCK1表达水平。结果饥饿处理后,C57BL/6小鼠空肠、回肠组织中G6PC、PCK1和SREBP1c表达水平均显著增加(P<0.05)。SREBP1c基因敲除后,小鼠空肠、回肠组织中由饥饿诱导的糖异生限速酶G6PC和PCK1的表达明显下调(P<0.05)。在肠上皮细胞CaCo-2中过表达SREBP1c,可显著上调糖异生途径关键酶G6PC和PCK1的表达,促进细胞内葡萄糖的产生(P<0.05);反之,敲低SREBP1c的表达,可明显下调G6PC和PCK1,抑制细胞内葡萄糖的产生(P<0.05)。结论饥饿状态下,SREBP1c可调控肠上皮细胞中糖异生限速酶G6PC和PCK1的表达,进而影响葡萄糖的生成,表明SREBP1c可能参与肠道糖异生的调控,机制有待进一步探索。
文摘目的筛选影响胆固醇调节元件结合蛋白1a(cholesterol regulatory element binding protein,SREBP1a)蛋白稳定性的去泛素化酶,并探索其调控机制。方法通过去泛素化酶库筛选显著影响SREBP1a表达的去泛素化酶,免疫蛋白印记实验和实时荧光定量PCR(qRT-PCR)评估去泛素化酶对SREBP1a以及升脂基因表达的影响;通过红色荧光蛋白标记人源低密度脂蛋白(human Dil-low density lipoprotein,Human Dil-LDL)摄取和油红O染色等实验技术检测细胞摄取低密度脂蛋白(LDL)和脂质沉积情况。结果去泛素化酶库筛选发现泛素特异肽酶37(ubiquitin specific peptidase 37,USP37)可显著增加肝细胞SREBP1a蛋白表达水平,促进胆固醇摄取及脂质沉积。USP37基因敲除可显著降低SREBP1a蛋白表达水平,抑制升脂基因表达及脂质沉积。结论去泛素化酶USP37通过稳定SREBP1a蛋白表达,促进胆固醇摄取及脂质沉积,揭示了SREBP1a翻译后调控的新模式。
基金This research received funding from the Natural Science Foundation of Shanghai(Grant No.20ZR1457600)the School-Level Basic Medical Project of Naval Medical University(Grant No.2021MS13).
文摘Background:Ossification of the posterior longitudinal ligament(OPLL)is a prevalent condition in orthopedics.While death-associated protein kinase 2(DAPK2)is known to play roles in cellular apoptosis and autophagy,its specific contributions to the advancement of OPLL are not well understood.Methods:Ligament fibroblasts were harvested from patients diagnosed with OPLL.Techniques such as real-time reverse transcriptasepolymerase chain reaction(RT-qPCR)and Western blot analysis were employed to assess DAPK2 levels in both ligament tissues and cultured fibroblasts.The extent of osteogenic differentiation in these cells was evaluated using an alizarin red S(ARS)staining.Additionally,the expression of ossification markers and autophagy markers was quantified.The autophagic activity was further analyzed through LC3 immunofluorescence and transmission electron microscopy(TEM).An in vivo heterotopic bone formation assay was conducted in mice to assess the role of DAPK2 in ossification.Results:Elevated DAPK2 expression was confirmed in both OPLL patient tissues and derived fibroblasts,in contrast to non-OPLL controls.Silencing of DAPK2 significantly curtailed osteogenic differentiation and autophagy in these fibroblasts,evidenced by decreased levels of LC3,and Beclin1,and reduced autophagosome formation.Additionally,DAPK2 was found to inhibit the mechanistic target of the rapamycin complex 1(mTORC1)complex’s activity.In vivo studies demonstrated that DAPK2 facilitates ossification,and this effect could be counteracted by the mTORC1 inhibitor rapamycin.Conclusion:DAPK2 enhances autophagy and osteogenic processes in OPLL through modulation of the mTORC1 pathway.
文摘For healthspan and lifespan,ERK,AMPK and mTORC1 represent critical pathways and inflammation is a centrally important hallmark1-7.Here we examined whether IL-11,a pro-inflammatory cytokine of the IL-6 family,has a negative effect on age-associated disease and lifespan.As mice age,IL-11 is upregulated across cell types and tissues to regulate an ERK-AMPK-mTORC1 axis to modulate cellular,tissue-and organismal-level ageing pathologies.Deletion of Il11 or Il11ra1 protects against metabolic decline,multi-morbidity and frailty in old age.
